Roche Holding Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AAPL | Apple | Outperform |
16
|
$183.38 | $200.65 | 9.06% | 12 | $2.67T |
| LLY | Eli Lilly and | Outperform |
16
|
$734.97 | $636.99 | 19.73% | 9 | $680.63B |
| AVGO | Broadcom | Outperform |
8
|
$1.28k | $1.21k | 21.66% | 11 | $573.98B |
| ABBV | AbbVie | Outperform |
9
|
$163.79 | $178.42 | 12.95% | 11 | $284.74B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £188.45B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.90 | $118.92 | 18.04% | 7 | $183.79B |
| DHR | Danaher | Outperform |
10
|
$248.38 | $260.33 | 9.68% | 4 | $182.83B |
| GE | General Electric | Outperform |
8
|
$164.11 | $144.00 | 9.69% | 3 | $178.03B |
| AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.80% | 8 | $149.32B |
| BSX | Boston Scientific | Buy |
11
|
$72.85 | $70.14 | 12.56% | 6 | $105.90B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $88.58B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $81.46B |
| BDX | Becton Dickinson and Co | Outperform |
9
|
$234.68 | $284.47 | 18.25% | 8 | $69.44B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.50k | ¥5.24k | 5.42% | 0 | ¥10.55T |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.09k | ¥4.92k | 20.73% | 0 | ¥8.38T |
| MMM | 3M | Hold |
10
|
$97.15 | $109.39 | 3.96% | 3 | $53.57B |
| DXCM | DexCom Inc | Buy |
12
|
$128.37 | $125.98 | 16.85% | 2 | $50.37B |
| A | Agilent Technologies | Outperform |
10
|
$139.45 | $138.82 | 8.28% | 10 | $40.30B |
| CTVA | Corteva | Outperform |
12
|
$57.16 | $61.72 | 13.72% | 1 | $39.89B |
| ALC | Alcon | Outperform |
8
|
CHF72.16 | CHF90.64 | 33.54% | 3 | CHF35.12B |
| DD | DuPont de Nemours | Outperform |
17
|
$77.67 | $75.38 | 6.86% | 14 | $32.51B |
| BIIB | Biogen | Outperform |
10
|
$217.51 | $299.62 | 32.64% | 13 | $31.09B |
| BAYN | Bayer | Hold |
5
|
28.02€ | 45.15€ | 7.07% | 4 | 27.64€B |
| 7751 | Canon | Hold |
18
|
¥4.28k | ¥3.74k | -11.24% | 0 | ¥3.69T |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.06k | kr2.71k | 28.09% | 14 | kr125.84B |
| CE | Celanese | Hold |
13
|
$157.17 | $148.23 | 1.80% | 18 | $17.45B |
| BGNE | BeiGene | Buy |
6
|
$162.25 | $285.19 | 69.49% | 2 | $16.96B |
| BIM | bioMérieux | Outperform |
18
|
98.70€ | 105.55€ | 15.50% | 1 | 11.82€B |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
39.26€ | 41.13€ | -1.94% | 12 | 11.62€B |
| 4523 | Eisai | Outperform |
18
|
¥6.55k | ¥9.58k | 28.34% | 0 | ¥1.86T |
| ERF | Eurofins Scientific | Hold |
18
|
56.68€ | 0.00€ | 5.86% | 5 | 11.11€B |
| TECH | Bio-Techne Corp | Buy |
16
|
$77.29 | $100.78 | 8.68% | 2 | $11.55B |
| EXAS | Exact Sciences | Buy |
8
|
$62.07 | $90.32 | 43.72% | 7 | $10.91B |
| BRKR | Bruker | Outperform |
16
|
$70.05 | $73.64 | 29.19% | 1 | $10.18B |
| CRDA | Croda International Plc | Outperform |
18
|
£47.46 | £65.12 | 7.46% | 6 | £6.43B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$279.83 | $536.80 | 50.09% | 1 | $7.74B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$107.19 | $85.71 | 2.62% | 5 | $6.72B |
| EXEL | Exelixis | Outperform |
16
|
$21.90 | $26.44 | 23.29% | 5 | $6.44B |
| GETI B | Getinge AB | Outperform |
18
|
kr232.30 | kr226.10 | -1.85% | 3 | kr64.01B |
| DIA | DiaSorin S.p.A. | Hold |
18
|
92.02€ | 102.04€ | 8.67% | 1 | 5.07€B |
| CLN | Clariant | Outperform |
18
|
CHF13.89 | CHF16.11 | 7.99% | 6 | CHF4.53B |
| BIOCON | Biocon | Hold |
14
|
Rp305.20 | Rp270.86 | -13.17% | 14 | Rp356.47B |
| ALKS | Alkermes | Outperform |
10
|
$24.05 | $33.27 | 33.06% | 3 | $4.06B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.82 | $9.50 | 21.48% | 5 | $3.21B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$12.00 | HK$3.96 | -68.00% | 0 | HK$24.72B |
| EKTA B | Elekta AB (publ) | Hold |
18
|
kr76.95 | kr83.00 | 1.36% | 3 | kr30.26B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥21.70 | ¥24.00 | -100.00% | 1 | ¥19.95B |
| 300676 | BGI Genomics | - |
17
|
¥41.13 | ¥0.00 | -100.00% | 0 | ¥15.61B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$25.38 | $23.40 | 0.87% | 4 | $2.08B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$4.45 | $14.09 | 135.96% | 2 | $918.17M |
| DHG | DHG Pharmaceutical Joint Stock | Hold |
18
|
113.50k | 125.44k | 2.73% | 0 | 14.92T |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$3.01 | $8.67 | 99.34% | 2 | $386.11M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.27 | $10.86 | 252.42% | 3 | $222.46M |
| ALIM | Alimera Sciences | Buy |
9
|
$3.65 | $7.00 | 119.18% | 3 | $185.33M |
| DBD | Binh Dinh Pharmaceutical and M... | Outperform |
15
|
₫53.10k | ₫62.90k | 9.23% | 1 | ₫3.97T |
| DCL | Cuu Long Pharmaceutical Joint ... | - |
12
|
₫27.00k | ₫0.00 | -100.00% | 0 | ₫1.99T |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£31.08 | £0.00 | -100.00% | 0 | £3.30B |
| DMC | Domesco Medical Import - Expor... | - |
0
|
₫56.20k | ₫0.00 | -100.00% | 0 | ₫1.74T |
| AGL | ANGLE | Buy |
8
|
£0.18 | £0.97 | 283.33% | 0 | £35.81M |
| BNGO | Bionano Genomics | Outperform |
6
|
$0.95 | $12.33 | 531.58% | 2 | $44.28M |
| DRIO | DarioHealth | Buy |
6
|
$1.57 | $4.70 | 218.47% | 1 | $34.42M |
| BCART | Biocartis Group NV | - |
7
|
0.29€ | 1.10€ | -100.00% | 0 | 27.24€M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.92 | $5.00 | -100.00% | 1 | $21.49M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.85 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| DBT | Ben Tre Pharmaceutical Joint S... | - |
8
|
₫12.90k | ₫0.00 | -100.00% | 0 | ₫207.33B |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |